市场调查报告书
商品编码
1252574
全球乳腺X光照相繫统市场按产品(模拟,全场数位(FFDM),乳房断层合成),技术(屏幕胶片,2D,3D),最终用途(医院,诊所)和全球预测2023-2032Mammography Systems Market - By Product (Analog Systems, Full Field Digital Mammography Systems (FFDM), Breast Tomosynthesis), By Technology (Screen Film, 2D Mammography, 3D Mammography), By End-use (Hospitals, Clinics) & Global Forecast, 2023-2032 |
由于对女性健康的关注日益增加,预计从 2023 年到 2032 年,乳腺X光摄影系统市场将以显着的复合年增长率增长。
乳房X光照相术是检测乳腺癌的主要诊断测试之一。 根据美国癌症协会的数据,女性死于乳腺癌的机率为 2.5%。 各个中央政府提供资金来改进筛选程序。 50 至 74 岁的女性有资格获得免费乳房 X 光检查。
乳房成像的最新发展是计算机辅助检测 (CAD) 技术。 在放射科医生对患者的乳房X光照片进行初步评估后,CAD 技术将图像作为第二隻眼进行检查。
乳房X光照相繫统行业按产品,技术,最终用途和地理区域划分。
根据产品,到 2032 年,模拟系统的价值预计将超过 1.5 亿美元。 更好的临床方法和更高的采用率将推动对模拟系统的需求。 这些系统还提供更先进的筛查,以帮助检测女性年轻或緻密的乳腺组织。
在技术方面,屏幕胶片乳腺X光摄影系统将在预计期间实现良好增长。 几十年来,屏幕胶片乳房 X 光摄影系统一直是乳腺癌筛查的标准。 屏幕胶片也是医学影像中要求最高的测试之一,要求对比度高,细节精细,图像噪声低,患者移动少和良好的观看条件。
就最终用途而言,从 2023 年到 2032 年,医院部分将获得显着收益,因为医院的乳腺成像设施可为所有年龄段的女性提供全方位的乳腺护理服务。 此外,多学科高科技技术的使用和以患者为中心的治疗方法是影响该细分市场增长的主要因素。 此外,医院熟练专业人员的可用性和改善的临床结果将推动未来几年的产品需求。
预计到 2032 年,亚太地区乳腺X光摄影系统市场价值将超过 15 亿美元。 年轻人和成年女性癌症发病率的上升以及对早期癌症诊断的需求不断增长,推动了该地区对筛查测试的需求。 此外,不断增加的医疗保健支出,越来越多地采用新技术,移动筛查工具的可用性等预计将在未来进一步刺激市场增长。
Mammography Systems Market will likely grow at a significant CAGR over 2023 to 2032 owing to the rising focus on women's health. Mammography is one of the leading diagnostic tests used to detect breast cancer. As per the American Cancer Society, the probability of a woman succumbing to breast cancer is nearly 2.5%. Various central governments are providing funds for improving screening programs. Besides, free mammogram screening services are available for women between 50 and 74 years of ages.
A recent development in breast imaging is computer-aided detection (CAD) technology. After the radiologist has produced an initial assessment of a patient's mammography film, the CAD technology acts as a second set of eyes by examining the image.
Overall, the mammography systems industry is segmented in terms of product, technology, end-use, and region.
Based on the product, the analog system is anticipated to be valued at over USD 150 million by 2032. Better clinical approach outcomes and a higher adoption rate will fuel the demand for analog systems. Besides, these systems deliver enhanced screening that helps detect young and dense breast tissue in women.
Considering the technology, the screen film mammography systems will observe lucrative growth during the estimated timespan. Screen-film mammography systems have been a standard for breast cancer screening for several decades. Besides, screen film is one of the most demanding examinations in medical imaging requiring high contrast, fine detail, low noise images, low patient motion, and appropriate viewing conditions.
By end-use, the hospitals segment will garner substantial gains during 2023-2032 as breast imaging facilities at hospitals offer enhanced breast care services to women of all ages. Besides, the use of multidisciplinary high-technology and patient-centered approaches to care are key factors impacting the segment growth. In addition, the availability of skilled professionals in hospitals and improved clinical outcomes will drive the product demand in the forthcoming years.
Geographically, the Asia Pacific mammography systems market is expected to be valued at over USD 1.5 billion by 2032. The rising incidences of cancer cases and increasing need for early cancer diagnosis among young and adult women will drive the screening procedure demand in the region. In addition, the constantly rising healthcare expenditure, increasing adoption of novel technologies, and availability of mobile screening tools will further spur market growth in the future.